Heparinase III

N/A

Report date: 2024/12/06 10:45:09

Base Information

Drug NameHeparinase III
Drug Alias NameExtravaseIBT-9302
ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme
Mechanisms of ActionHeparinase stimulants
TargetsHeparinase
Therapy Area/IndicationsVascular restenosisVaricose UlcerReperfusion Injury +[4
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBiomarin Pharmaceutical Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiomarin Pharmaceutical Inc
Active IndicationsN/A
Inactive IndicationsVascular restenosisVaricose UlcerReperfusion Injury +[4

Other Information

ATC CodeN/A
Related LinksN/A